argus

Syngene International Limited

NSE: SYNGENEINE398R0102216,183 Cr

Timeline

Time (IST)TypeMEventSrc
12 Nov, 08:14 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
12 Nov, 08:04 pmSyngene International Limited has informed the Exchange about Transcriptnse
06 Nov, 07:00 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
06 Nov, 06:47 pmSyngene International Limited has informed the Exchange about Link of Recordingnse
06 Nov, 01:13 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
06 Nov, 01:08 pmSyngene International Limited has informed the Exchange about Investor Presentationnse
05 Nov, 08:53 pmSyngene International Limited has informed the Exchange regarding Board meeting held on November 05, 2025.nse
05 Nov, 08:49 pmSyngene International Limited has informed the Exchange regarding a press release dated November 05, 2025, titled "Second quarter revenue from operations grows 4% sequentially and 2% year-on-year to Rs. 911 Cr 1st half revenue from operations up 6%".nse
05 Nov, 08:48 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
05 Nov, 08:45 pmSyngene International Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
05 Nov, 08:44 pmSyngene International Ltd - 539268 - Unaudited Financial Results For The Quarter & Half Year Ended September 30, 2025.bse
04 Nov, 05:48 pmSyngene International Ltd - 539268 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
04 Nov, 05:39 pmSyngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
28 Oct, 04:24 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Change in Managementbse
28 Oct, 04:13 pmSyngene International Limited has informed the Exchange regarding the Appointment of Mr. Surender Sharma as General Counsel and a member of the Executive Committee (Senior Management Personnel) of the Company w.e.f. October 28, 2025.nse
24 Oct, 02:53 pmThe Exchange has sought clarification from Syngene International Limited with respect to recent news item captioned Syngene expands Biologics facility with new ADC bioconjugation capability. The response from the Company is attached.nse
23 Oct, 09:59 pmSyngene International Limited has informed the Exchange about Rumour Verification - Regulation 30(11)nse
23 Oct, 02:01 pmThe Exchange has sought clarification from Syngene International Limited with respect to recent news item captioned Syngene expands Biologics facility with new ADC bioconjugation capability. The response from the Company is awaited.nse
18 Oct, 09:10 pmSyngene International Limited has informed the Exchange about Email communication to shareholders under 100 Days Campaign 'Saksham Niveshak'nse
09 Oct, 06:11 pmSyngene International Ltd - 539268 - Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ending September 30, 2025.bse
27 Sept, 05:16 pmSyngene International Ltd - 539268 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
27 Sept, 05:07 pmSyngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
09 Sept, 11:02 amSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
09 Sept, 11:02 amSyngene International Limited has informed the Exchange about Investor Presentationnse
04 Sept, 03:16 pmSyngene International Ltd - 539268 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
01 Sept, 10:44 pmSyngene International Limited has informed the Exchange regarding 'Grant of Performance Share Units under Syngene Long-Term Incentive Performance Share Plan 2023 (Plan)'.nse